EMD SERONO INC FDA Approval NDA 021197

NDA 021197

EMD SERONO INC

FDA Drug Application

Application #021197

Documents

Letter2004-05-07
Letter2004-05-07
Label2000-08-11
Review2000-08-11
Letter2000-08-11
Letter2004-05-07
Letter2008-04-10
Label2008-04-16
Letter2021-08-04

Application Sponsors

NDA 021197EMD SERONO INC

Marketing Status

Prescription001
Discontinued002

Application Products

001INJECTABLE;INJECTIONEQ 0.25MG BASE/ML1CETROTIDECETRORELIX
002INJECTABLE;INJECTIONEQ 3MG BASE/ML0CETROTIDECETRORELIX

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2000-08-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2000-12-13STANDARD
LABELING; LabelingSUPPL3AP2004-04-30STANDARD
LABELING; LabelingSUPPL4AP2004-04-30STANDARD
LABELING; LabelingSUPPL5AP2004-04-30STANDARD
LABELING; LabelingSUPPL10AP2008-04-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2013-01-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2013-03-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2013-03-13STANDARD
LABELING; LabelingSUPPL18AP2017-12-22STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL18Null15

TE Codes

001PrescriptionAP

CDER Filings

EMD SERONO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21197
            [companyName] => EMD SERONO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CETROTIDE","activeIngredients":"CETRORELIX","strength":"EQ 0.25MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"CETROTIDE","activeIngredients":"CETRORELIX","strength":"EQ 3MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"04\/04\/2008","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021197s010lbl.pdf\"}]","notes":""},{"actionDate":"08\/11\/2000","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/21197lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"CETROTIDE","submission":"CETRORELIX","actionType":"EQ 0.25MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"CETROTIDE","submission":"CETRORELIX","actionType":"EQ 3MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2008-04-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.